Weed Stocks on Fire After Amazon Gives Stamp of Approval

As the CEO of one of the largest companies in the world, Jeff Bezos’s endorsement of weed legalization carries weight.

| More on:
edit Jars of marijuana

Image source: Getty Images

People in the position of power — presidents, parliamentarians, members of Congress, provincial premiers — often have the power to sway the market with their decisions and comments. But they aren’t the only people with that power. Investors and business magnates like Warren Buffett can also influence the market (up to a certain degree).

That’s the power that allowed Jeff Bezos to stir the marijuana market in the U.S. and Canada. Bezos openly endorsed the initiative of the U.S. government to legalize marijuana on a federal level, and this endorsement was powerful enough to boost several weed stocks.

Amazon and marijuana legalization

Amazon’s CEO didn’t just verbally endorse the U.S. government’s Marijuana Opportunity Reinvestment and Expungement (MORE) Act; he also made changes to the company’s hiring policy. The company has dropped marijuana screening of potential employees, except for positions under the purview of regulatory bodies like the Department of Transportation.

Amazon is the second-largest employer in the U.S. (after Walmart), and this move will most likely be followed by other major employers, especially in the tech sector. The snowball effect it has the potential to create can be enough of a nudge to the federal government.

If the U.S. government legalizes recreational cannabis on a federal level, it will open up a great new market for Canadian weed companies, many of whom are already focused on consolidating territories and bringing the relevant brands under their fold. Thanks to its extensive e-commerce network, Amazon will undoubtedly be a key player in helping Canadian weed companies penetrate the U.S. market without local retail locations.

A weed stock on fire

Following the news, several cannabis stocks rose in value, and one of them was the Toronto-based Cronos Group (TSX:CRON)(NASDAQ:CRON). The stock rose by at least 10% before normalizing. Cronos group markets itself as a true global cannabinoid company. The company has six major brands under its banner; two of them already have a decent presence in the U.S., and one’s presence is anticipated.

The company focuses on the technology and innovative aspects of the cannabis market. It’s also focusing on building a global network of partner businesses and developing its global supply chain. Cronos has a strong balance sheet. Even though its revenues are having difficulty normalizing, the company is adequately U.S.-facing to take full advantage of the marijuana legalization in the country.

Cronos stock is trading a massive discount compared to both its 2019 peak (over 64%) and its recent peak of 47.5%.

Foolish takeaway

The MORE act is expected to do more than just remove cannabis from the list of controlled substances, though that will be the most economically impacting factor. A decent number of states have already legalized cannabis for both medical and recreational uses, and others are in the process of legalizing the substance. It’s all culminating towards a logical end. All investors have to do now is to find the right weed stocks and get the timing right to maximize their returns from the potential boom.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

John Mackey, CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool’s board of directors. The Motley Fool owns shares of and recommends Amazon. The Motley Fool recommends the following options: long January 2022 $1,920 calls on Amazon and short January 2022 $1,940 calls on Amazon. Fool contributor Adam Othman has no position in any of the stocks mentioned. 

More on Cannabis Stocks

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Can Canopy Growth Stock Finally Recover in 2024?

Down 98% from all-time highs, Canopy Growth remains a high-risk investment in 2024 given its weak fundamentals.

Read more »

A close up image of Canadian $20 Dollar bills
Tech Stocks

3 No-Brainer Stocks to Buy With $20 Right Now

These three stocks are easy buys for those who don't have all that much to spend, and want long-term growth…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Slow Burn: Is Aurora Cannabis Finally a Good Buy in June?

One of the benefits of choosing from some of the most beaten-down market segments like cannabis is that even a…

Read more »

Caution, careful
Cannabis Stocks

I Wouldn’t Touch This TSX Stock With a 60-Foot Pole

I wouldn't touch Canopy Growth Corp (TSX:WEED) stock with a 60-foot pole.

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Why This Little-Known Cannabis Stock Could Double in 2024

This cannabis stock has already doubled this year since 52-week lows and could easily rise that much once more.

Read more »

Bad apple with good apples
Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 420-Foot Pole

Down 87% from all-time highs, Cronos Group stock is a still a high-risk investment for long-term shareholders in 2024.

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth: Buy, Sell, or Hold?

Canopy Growth (TSX:WEED) stock should make a killing on U.S. expansion, but investors will need to be very patient.

Read more »

Marijuana plant and cannabis oil bottles isolated
Energy Stocks

3 Canadian Value Stocks to Buy Right Now

Undervalued Canadian stocks such as Secure Energy should be part of your shopping list in May 2024.

Read more »